GlassScriptPhysician profile
Sarah B White
NPI 1710043013
$98,494.75
in general payments reported to CMS, 2019-2025
22 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,312 · 2020: $3,671 · 2021: $23K · 2022: $15K · 2023: $16K · 2024: $27K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Honoraria: $2,000 · Food and Beverage: $1,785 · Travel and Lodging: $1,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,190.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,180.00 |
| Honoraria | $2,000.00 |
| Food and Beverage | $1,785.27 |
| Travel and Lodging | $1,577.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $43,110.70 | 2019-2024 | Zilver Ptx, Cook, Tornado |
| Medtronic, INC. | $12,143.23 | 2021-2025 | Concertotm, Abre, Concerto Versa |
| Boston Scientific Corporation | $9,809.90 | 2019-2025 | Obsidio, General - Interventional Oncology, Embold Fibered |
| Penumbra, INC. | $7,127.31 | 2021-2023 | Ruby Coil, Indigo System |
| Astrazeneca Pharmaceuticals LP | $6,205.49 | 2022-2025 | Imfinzi |
| Siemens Medical Solutions USA, INC. | $5,033.06 | 2022-2024 | Truebeam, Embozene, Acuson Origin Diagnostic Ultrasound System |
| Wilson Cook Medical Incorporated | $3,275.00 | 2022 | |
| Guerbet LLC | $2,763.90 | 2019-2025 | Lipiodol |
| Merck Sharp & Dohme LLC | $2,440.00 | 2024 | |
| Trisalus Life Sciences, INC. | $2,320.41 | 2022-2024 | Trinav Infusion System |
| Eisai INC. | $2,205.00 | 2024 | |
| Angiodynamics, INC. | $722.95 | 2019-2021 | |
| Cook Medical LLC | $441.48 | 2020-2024 | Cook, Zenith Spiral-Z |
| Sirtex Medical INC | $304.85 | 2019-2022 | |
| Inari Medical, INC. | $189.03 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Delcath Systems | $161.18 | 2025 | Hepzato Kit |
| Ge Healthcare | $143.80 | 2024 | |
| Thrombolex, INC. | $51.75 | 2024 | Bashir Endovascular Catheter |
| Instylla, INC. | $23.02 | 2023 | Instylla Delivery Kit, Instylla Microcatheter |
| Surmodics, INC. | $22.69 | 2025 | Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.